Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15667949

Int. J. Radiat. Oncol. Biol. Phys. 2005 Feb 1 61 2 318-28

Download in:

View as

General Info

PMID
15667949